Abstract:Introduction: The Er:YAG laser, considered to be less effective than CO2 laser in its traditional form, in its new modulated version has variable pulse technology that is claimed to be superior to the earlier versions of the laser. Aim: The aim of the study was to check efficacy and safety of the new variable square pulse (VSP) Er:YAG laser in the management of acne scar in patients with Fitzpatrick skin types IV and V. Materials and methods: This retrospective study consisted of 80 patients (Fitzpatrick skin types IV and V) with atrophic and hypertrophic facial acne scars. Records of the patients who had undergone four treatment sessions with VSP technology equipped with Er:YAG laser were extracted. Each patient had undergone a minimum of four sessions. Fractional mode at medium laser pulse (SP) and long pulse (LP) was employed for the depressed center of the scars to stimulate neocollagenogenesis. Short laser pulse (MSP) in nonfractionated mode was used for ablating the raised scar border and hypertrophic scars. Goodman and Baron global scarring grading system was used for qualitative and quantitative assessments. Patient's satisfaction to the treatment and observer's assessment of improvement (based on photographs) was graded as poor (<25% improvement), fair (25-50% improvement), good (51-75% improvement), and excellent (>75% improvement). Results: At the end of the four sessions, the number of patients in grade IV postacne scarring reduced from 16 to 2 and that in grade III from 47 to 29. The mean score significantly dropped from 36.94 to 27.5. Subjective assessment revealed that 78 of 80 patients had noticed more than 25% improvement, with 50 of them showing more than 50% improvement at the end of four sessions. Eight patients perceived an excellent response and 42 reported a good response. This is notably higher than the observer's grading, which showed an excellent response in only 2 patients and a good response in 35. Adverse effects were limited to prolonged erythema (two patients), prolonged crusting (one patient), and postinflammatory hyperpigmentation (one patient). Conclusion: Ninety-seven percent of the subjects in our study perceived at least a fair improvement. We also saw a significant change in the objective score with a fall of the mean quantitative score from 36.94 to 27.15. This underscores the new variable-pulsed Er:YAG laser's effectiveness in the treatment of acne scars. It also has the added advantage of lesser adverse events and faster healing.

Fast and effective skin ablation with an Er:YAG laser: determination of ablation rates and thermal damage zones

Ablation Efficiency of a Novel Thulium Fiber Laser: an in Vitro Study on Laser Setting and Fiber Usage.

Influence of tissue desiccation on critical temperature for thermal damage during Er:YAG laser skin treatments

The effects of variable pulse width of Er:YAG laser on facial skin

Nonablative skin remodeling: selective dermal heating with a mid-infrared laser and contact cooling combination

Modulating the Er:YAG laser

Evaluation of a Novel Ablative 1940 nm Pulsed Laser for Skin Rejuvenation

Er : Yag Laser Radiation in Experimental Ophthalmologic Applications

Ablation-cooled material removal with ultrafast bursts of pulses

Ultrafast dynamics of hard tissue ablation using femtosecond-lasers

Ablation Effect Comparison of Solid State Midinfrared Lasers Applied to TMLR

Resurfacing of pitted facial acne scars using Er:YAG laser with ablation and coagulation mode

In vivo experimental evaluation of skin remodeling by using an Er:Glass laser with contact cooling

High‐powered 675‐nm laser: Safety and efficacy in clinical evaluation and in vitro evidence for different skin disorders

Comparison Of Laser Phacovaporization Using The Er-Yag And The Er-Ysgg Laser

Cutting and coagulation during intraoral soft tissue surgery using Er: YAG laser

Resurfacing of Facial Acne Scars With a New Variable-Pulsed Er:YAG Laser in Fitzpatrick Skin Types IV and V

Will Repeated Ablative Er:YAG Laser Treatment Sessions Cause Facial Skin Sensitivity? Results of a 12-Month, Prospective, Randomized Split-Face Study.

Focal point technology: Controlling treatment depth and pattern of skin injury by a novel highly focused laser

Comparison of fractionated frequency-doubled 1,064/532 nm picosecond Nd:YAG lasers and non-ablative fractional 1,540 nm Er: glass in the treatment of facial atrophic scars: a randomized, split-face, double-blind trial

Histological evaluation of vertical laser channels from ablative fractional resurfacing: an ex vivo pig skin model